Targeted Therapies in Lung Cancer Patient Forum: Marijuana Use

Oncology Insights Forum - 4 Clinical Updates in Lung Cancer - 20 MarПодробнее

2023 Best of Lung: Panel Discussion on Targeted TherapyПодробнее

Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

Full Event Mainstage 2023 Targeted Therapies in Lung Cancer Patient Forum ON-DEMANDПодробнее

Nutrition During Cancer Treatment - 2022 Program: Targeted Therapies ForumПодробнее

2023 Best of Lung: Targeted Therapies in Lung CancerПодробнее

Breakout Second Stage 2023 Targeted Therapies in Lung Cancer Forum ON-DEMANDПодробнее

Metastatic EGFR+ NSCLC: Recent Developments - Targeted Therapies in Lung Cancer 2023Подробнее

EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

When Should Progression Lead to Treatment Changes? - 2022 Program: Targeted Therapies ForumПодробнее

Treatment of HER2+ NSCLC - 2022 Program: Targeted Therapies ForumПодробнее

BRAF Mutations in NSCLC - 2022 Program: Targeted Therapies ForumПодробнее

BRAF/MEK Combination in BRAF V600E+ Disease - 2022 Program: Targeted Therapies ForumПодробнее

Treatment for NTRK+ NSCLC: Larotrectinib & Entrectinib - 2022 Program: Targeted Therapies ForumПодробнее

Progression on Sotorasib with KRAS+ NSCLC - 2022 Program: Targeted Therapies ForumПодробнее

RET+ NSCLC Treatment Options - 2022 Program: Targeted Therapies ForumПодробнее

Trials in HER2+ NSCLC - 2022 Program: Targeted Therapies ForumПодробнее

HER2+ NSCLC: When to Introduce Targeted Therapies - 2022 Program: Targeted Therapies ForumПодробнее

Treatment Strategies for KRAS+ NSCLC - 2022 Program: Targeted Therapies ForumПодробнее

Treatments for RET+ NSCLC: Selpercatinib vs. Pralsetinib - 2022 Program: Targeted Therapies ForumПодробнее